Shares of RTW Biotech Opportunities (LON:RTW – Get Free Report) shot up 0.9% on Tuesday . The stock traded as high as GBX 2.25 and last traded at GBX 2.24. 233,452 shares changed hands during trading, a decline of 72% from the average session volume of 822,817 shares. The stock had previously closed at GBX 2.22.
RTW Biotech Opportunities Trading Up 0.9%
The company has a current ratio of 0.15, a quick ratio of 0.81 and a debt-to-equity ratio of 20.05. The company has a 50-day simple moving average of GBX 2.19 and a 200 day simple moving average of GBX 2.12. The firm has a market cap of £7.25 million, a PE ratio of 0.04 and a beta of 1.24.
About RTW Biotech Opportunities
RTW Biotech Opportunities Ltd (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Bio invests in companies developing next-generation therapies and technologies that can significantly improve patients’ lives. RTW Bio is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.
Featured Articles
- Five stocks we like better than RTW Biotech Opportunities
- Oracle’s Sell-Off Looks More Like a Mispricing Than a Warning
- Apple’s Intel Deal Arrives at the Right Time for Its Stock
- Liquid Gold: The AI Cooling Retrofit Trade
- 3 Dividend Stocks Under $30 to Anchor Your Portfolio
Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.
